How should severe aortic stenosis be managed in the emergency department?

Emergency Department Management of Severe Aortic Stenosis

Stabilize hemodynamics immediately with cautious fluid resuscitation and vasopressors (if hypotensive), arrange urgent cardiology consultation for definitive valve intervention, and avoid aggressive afterload reduction that can precipitate cardiovascular collapse.

Immediate ED Stabilization

The cornerstone of ED management is hemodynamic optimization while preparing for urgent valve intervention 1. Patients with decompensated severe aortic stenosis are critically dependent on preload and heart rate, making standard heart failure management potentially lethal.

Critical Hemodynamic Principles

• Restore and maintain preload: These patients require adequate filling pressures to maintain cardiac output across a fixed stenotic valve. Aggressive diuresis is dangerous 1

• Maintain normal sinus rhythm and heart rate: Both bradycardia and tachycardia cause rapid decompensation. Bradycardia reduces cardiac output directly; tachycardia shortens diastolic filling time, reducing preload 1

• Cautious vasodilator use: If hypertensive with heart failure symptoms, nitrates may be reasonable, but hypotension must be avoided. The stenotic valve prevents compensatory increases in stroke volume 1

• Vasopressor support when needed: For hypotensive patients, use vasopressors at the lowest effective dose. Phenylephrine or norepinephrine are preferred to maintain coronary perfusion pressure 1

• Dobutamine for inotropy: Can increase contractility in patients with reduced ejection fraction, but use cautiously as increased contractility increases myocardial oxygen demand 1

Diagnostic Workup

Obtain immediately:

• Electrocardiogram: Look for left ventricular hypertrophy, strain patterns, conduction abnormalities
• Complete blood count, basic metabolic panel, coagulation studies: Assess for precipitants and surgical candidacy
• Troponin: Elevated in many patients due to supply-demand mismatch
• BNP: Correlates with severity and prognosis
• Type and screen: Prepare for potential urgent intervention
• Chest radiograph: Assess for pulmonary edema, cardiomegaly 1

Transthoracic echocardiography is the definitive diagnostic test and should be obtained emergently 1. Point-of-care ultrasound by trained emergency physicians can identify severe AS with 75% sensitivity and 92.5% specificity when evaluating parasternal long and short axis views for absent cusp movement 2, though formal echocardiography remains the gold standard.

Definitive Management Strategy

Symptomatic Severe AS: Intervention is Mandatory

For symptomatic patients with severe high-gradient AS (Vmax ≥4 m/sec or mean gradient ≥40 mmHg), aortic valve replacement is indicated regardless of surgical risk 3. The 2021 ESC/EACTS and 2020 ACC/AHA guidelines both give this a Class I, Level B recommendation 3.

Emergency Intervention Options

The evidence comparing emergency strategies reveals important mortality differences:

Urgent/emergency TAVI is superior to balloon aortic valvuloplasty (BAV) as a bridge to elective intervention 4. A 2021 cohort study demonstrated:

• 30-day mortality: 2.3% for emergency TAVI vs 11.5% for emergency BAV (p<0.05)
• 1-year mortality: 11.5% for emergency TAVI vs 55.8% for emergency BAV (p<0.001)
• Adjusted hazard ratio for BAV: 11.2 (95% CI: 4.67-26.9) 4

However, a 2018 multicenter study showed both approaches have significant early mortality in cardiogenic shock:

• Immediate procedural mortality: 8.7% for emergency TAVI vs 20.3% for emergency BAV (p=0.19)
• 30-day cardiovascular mortality: 23.8% for emergency TAVI vs 33.0% for emergency BAV (p=0.40)
• Emergency TAVI had higher rates of major vascular complications and stroke 5

Clinical Decision Algorithm

For patients in cardiogenic shock with severe AS:

1. If TAVI-capable center with immediate availability: Consider emergency TAVI if anatomy suitable and no contraindications 4

2. If TAVI not immediately available or unsuitable anatomy: Emergency BAV as bridge to definitive intervention, recognizing high mortality risk 5, 4

3. If surgical candidate with favorable anatomy: Emergency surgical AVR can be lifesaving even in cardiogenic shock with multiorgan failure. A 1997 case series showed 100% survival in patients with critical AS (valve area 0.56±0.13 cm²), LVEF 20±3%, and multiorgan failure who underwent emergency SAVR 6

Special Considerations for Low-Flow, Low-Gradient AS

With reduced LVEF (<50%): Intervention is appropriate regardless of surgical risk if truly severe AS is confirmed 7. Use dobutamine stress echo to distinguish true severe AS from pseudosevere AS 7.

With preserved LVEF: Intervention is appropriate if AS is the most likely cause of symptoms after careful confirmation of severity 3.

Common Pitfalls to Avoid

• Aggressive diuresis: Reduces preload and can precipitate cardiovascular collapse
• Nitroprusside or aggressive afterload reduction: Can cause profound hypotension without ability to compensate
• Atrial fibrillation with rapid ventricular response: Loss of atrial kick and shortened diastolic filling is poorly tolerated—restore sinus rhythm urgently
• Delaying definitive intervention: Symptomatic severe AS has dismal prognosis without valve replacement; mortality approaches 50% at 2 years without intervention 1
• Assuming BAV is adequate definitive therapy: BAV is a temporizing measure only, with high reintervention and mortality rates 5, 4

Disposition

All patients with decompensated severe AS require:

• Immediate cardiology/cardiac surgery consultation
• ICU admission for hemodynamic monitoring
• Urgent multidisciplinary Heart Team evaluation for definitive intervention timing and modality 3
• Consideration for transfer to TAVI-capable center if not available at presenting facility

The treatment of choice is valve replacement (TAVI or SAVR), with extracorporeal membrane oxygenation and percutaneous BAV serving only as temporizing measures in extremis 1.